rawfin.tv
Guardant Health's Shield Test Gains Carelon Health Coverage
MarketsstocksAI Generated

Guardant Health's Shield Test Gains Carelon Health Coverage

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Guardant Health announced that its Shield™ blood test for colorectal cancer screening will now be covered by Carelon Health Services. This coverage expands access to the diagnostic test and represents a significant positive development for Guardant Health.

Guardant HealthHealthcareMedical DevicesInsurance Coverage

Related Articles

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

stocks
SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

stocks
Elon Musk Explores Merger Between SpaceX and Tesla

Elon Musk Explores Merger Between SpaceX and Tesla

stocks
Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks